A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma

Jonathan E. Dowell, Frank R. Dunphy, Robert N. Taub, David E. Gerber, Likheng Ngov, Jingsheng Yan, Yang Xie, Hedy Lee Kindler

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma'. Together they form a unique fingerprint.

Medicine & Life Sciences